Study on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With Inhibitors

NCT04789954 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A With Inhibitor
Hemophilia B With Inhibitor

Interventions

BIOLOGICAL: Eptacog alfa, activated

Sponsor

AryoGen Pharmed Co.